Kraig Biocraft Laboratories Inc (KBLB)

[TRUISM]

On the OTC, investors are presently paying less than eighteen cents a share...

IF KBLB makes it onto the Nasdaq, shares will be in the several dollar range; for just one; after the r/s.

Potentiated contracts are just that; driven by the HOPES of consistent productionr....

Try and sell mass-production potential to the savvy NASDAQ investor, as you dilute shares at a discount.


KBLB/Prodigy hasn't even produced several hundred pounds in consecutive production runs and wants to convince the world they can commercialize (in major quantities) at the drop of a hat?




More like an intended "blitz·krieg."


In résponse to:

I don't understand why this board treats the R/S like a boogeyman. The ratio does not matter at all, other than being able to meet the price for the uplist. There is no difference in value and the liquidity argument is ridiculous considering there will still be millions of shares to trade even at 100:1.

The dilution included with the R/S will have a tiny effect on your overall ownership. The cash from that dilution will be invaluable for growing the production capabilities.

The ability to attract institutional investors will have a massive benefit on the share price initially and will allow the share price to stabilize after the first run.

It's the best move Kim could make. I truly don't understand why the R/S would keep someone from buying or cause someone to sell this company.

TRUTH